GC012F Injection in Refractory Idiopathic Inflammatory Myopathy

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
GC012F Injection in Refractory Idiopathic Inflammatory Myopathy	muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease	Recruiting	Early phase 1	2026-01-14		NCT07086404

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
AstraZeneca Global R&D (China) Co., Ltd.	2
Daishi Tian	6
Gracell Biotechnologies (Shanghai) Co., Ltd.	11

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Tongji Hospital of Tongji Medical Colledge, Huazhong University of Science and Technology	Wuhan	China	1

Clinical trials